Syncom Formulations is trading 5.29% down at ₹20.07, with no clear company-specific announcement identified to explain the decline.
- The latest located filing was a routine compliance certificate dated October 8, 2026.
- Indian equities opened lower on October 26, with the Sensex down 0.74% and Nifty down 0.94% in morning trading amid elevated crude prices and geopolitical concerns. Broad weakness may be contributing, but pharma stocks were comparatively stronger, leaving the specific driver unclear.